PL3926051T3 - Sposoby zbierania hodowli komórek ssaczych - Google Patents

Sposoby zbierania hodowli komórek ssaczych

Info

Publication number
PL3926051T3
PL3926051T3 PL21179944.0T PL21179944T PL3926051T3 PL 3926051 T3 PL3926051 T3 PL 3926051T3 PL 21179944 T PL21179944 T PL 21179944T PL 3926051 T3 PL3926051 T3 PL 3926051T3
Authority
PL
Poland
Prior art keywords
methods
mammalian cell
cell cultures
collecting mammalian
collecting
Prior art date
Application number
PL21179944.0T
Other languages
English (en)
Inventor
Chetan Goudar
Sean Cole
Nicole Sabo
Henry Lin
Jonathan Craig LULL
Tharmala THARMALINGAM
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53433304&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3926051(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of PL3926051T3 publication Critical patent/PL3926051T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/04—Filters; Permeable or porous membranes or plates, e.g. dialysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10—Perfusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/16—Hollow fibers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
    • C12M33/14—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus with filters, sieves or membranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/48—Automatic or computerized control
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/02—Separating microorganisms from the culture medium; Concentration of biomass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12—Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Sustainable Development (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Computer Hardware Design (AREA)
  • Water Supply & Treatment (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
PL21179944.0T 2014-06-04 2015-06-04 Sposoby zbierania hodowli komórek ssaczych PL3926051T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462007588P 2014-06-04 2014-06-04

Publications (1)

Publication Number Publication Date
PL3926051T3 true PL3926051T3 (pl) 2024-08-26

Family

ID=53433304

Family Applications (2)

Application Number Title Priority Date Filing Date
PL15730015T PL3152317T3 (pl) 2014-06-04 2015-06-04 Sposoby zbierania hodowli ssaczych komórek
PL21179944.0T PL3926051T3 (pl) 2014-06-04 2015-06-04 Sposoby zbierania hodowli komórek ssaczych

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL15730015T PL3152317T3 (pl) 2014-06-04 2015-06-04 Sposoby zbierania hodowli ssaczych komórek

Country Status (25)

Country Link
US (3) US11384378B2 (pl)
EP (4) EP3521440B1 (pl)
JP (3) JP6695814B2 (pl)
KR (2) KR102598799B1 (pl)
CN (1) CN106687575B (pl)
AU (5) AU2015269365A1 (pl)
BR (2) BR112016028285B1 (pl)
CA (2) CA2951046C (pl)
CL (2) CL2016003096A1 (pl)
CY (1) CY1121217T1 (pl)
DK (2) DK3152317T3 (pl)
EA (2) EA202192126A3 (pl)
ES (3) ES2909630T3 (pl)
FI (1) FI3926051T3 (pl)
HU (2) HUE042277T2 (pl)
IL (3) IL319240A (pl)
LT (2) LT3926051T (pl)
MX (3) MX384212B (pl)
PL (2) PL3152317T3 (pl)
PT (2) PT3926051T (pl)
SG (2) SG10202113019XA (pl)
SI (2) SI3152317T1 (pl)
TR (1) TR201900776T4 (pl)
WO (1) WO2015188009A1 (pl)
ZA (1) ZA201608303B (pl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014218715B2 (en) 2013-02-22 2019-12-12 Genzyme Corporation Microcarrier perfusion culturing methods and uses thereof
MX367025B (es) 2013-02-22 2019-08-02 Genzyme Corp Metodos de cultivo por perfusion con microportadores y usos de los mismos.
TW202204596A (zh) 2014-06-06 2022-02-01 美商健臻公司 灌注培養方法及其用途
TW202246486A (zh) 2014-06-09 2022-12-01 美商健臻公司 種子罐培養法(seed train processes)及其用途
MX383857B (es) * 2014-12-22 2025-03-14 Genzyme Corp Métodos de cultivo de una célula de mamífero.
JOP20160086B1 (ar) 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
CN109689191B (zh) * 2016-07-25 2021-11-19 瑞普利金公司 交替切向流快速收获
JP7043125B2 (ja) * 2016-10-28 2022-03-29 旭化成メディカル株式会社 連続培養における有用物質の回収方法
CN107964037A (zh) * 2017-05-16 2018-04-27 浙江海隆生物科技有限公司 基于cho细胞表达系统的重组猪瘟e2蛋白的纯化方法及应用
EP3639171A4 (en) * 2017-06-16 2021-07-28 Cytiva Sweden AB PROCESS FOR PREDICTING THE RESULT AND MODELING A PROCESS IN A BIOREACTOR
KR20200042532A (ko) 2017-08-31 2020-04-23 메사추세츠 인스티튜트 오브 테크놀로지 생물학적으로 생성된 생성물을 제조하기 위한 중공 섬유 멤브레인 여과 시스템 및 방법
IL273549B2 (en) * 2017-10-06 2023-10-01 Lonza Ag Automated control of cell culture using Raman spectroscopy
JP7057423B2 (ja) 2017-10-26 2022-04-19 レプリゲン・コーポレイション 微小交互接線流灌流フィルタ、処理容器およびその使用方法
IL274776B2 (en) 2017-11-20 2025-02-01 Lonza Ag Process and system for growing cell cultures while preventing lactate accumulation
EP3770266A4 (en) * 2018-03-19 2021-06-09 FUJIFILM Corporation PRODUCT MANUFACTURING PROCESS
GB201810772D0 (en) * 2018-06-29 2018-08-15 Ge Healthcare Bio Sciences Ab Method in bioprocess purification system
EP4368699A3 (en) * 2018-07-03 2024-09-11 Bristol-Myers Squibb Company Methods of producing recombinant proteins
SG11202104417UA (en) * 2018-11-02 2021-05-28 Wuxi Biologics Ireland Ltd Cell culture process by intensified perfusion with continuous harvest and without cell bleeding
WO2020132231A1 (en) * 2018-12-21 2020-06-25 Genentech, Inc. Methods of producing polypeptides using a cell line resistant to apoptosis
WO2020142445A1 (en) 2018-12-31 2020-07-09 Repligen Corporation Filter for mammalian cell culture perfusion and clarification with hydrophobic hollow fiber
KR20220038749A (ko) * 2019-08-13 2022-03-29 리플리겐 코포레이션 고체 함량이 높은 셀 배양의 자동 정화를 위한 제어 시스템 및 방법
JP2023503849A (ja) 2019-11-15 2023-02-01 ロンザ リミテッド 接種物を生産するためのプロセスおよびシステム
US20220389363A1 (en) * 2020-01-10 2022-12-08 Lonza Walkersville, Inc. Filter Apparatus and Method for Purifying Biological Processes and Cell Populations
JP2023511291A (ja) * 2020-01-15 2023-03-17 ウーシー バイオロジクス アイルランド リミテッド 培養細胞から生産された生体物質を連続的に収穫するための装置及び方法
CN111808797A (zh) * 2020-07-28 2020-10-23 湖南赛诺生物科技股份有限公司 Necrostatin-1的应用及促进新生猪胰岛细胞成熟的制剂
EP3985097A1 (en) * 2020-10-14 2022-04-20 Sartorius Stedim Biotech GmbH A method and system for configuring and/or setup of a downstream process for processing a biomass
JP2023546736A (ja) * 2020-10-15 2023-11-07 エージーシー バイオロジクス，インコーポレーテッド 二重容器接線流濾過による連続的高細胞密度培養
US20220119759A1 (en) * 2020-10-19 2022-04-21 Emd Millipore Corporation Cascade Tangential Flow Filtration Systems for Perfusion of Cell Culture
US20220268785A1 (en) * 2021-02-19 2022-08-25 Northwestern University Facile sample preparation for quantitative single-cell proteomics
CN117561325A (zh) * 2021-02-25 2024-02-13 安全电池股份有限公司 用于生物技术应用的流体取样系统及其操作方法和用途
FR3126713A1 (fr) * 2021-09-08 2023-03-10 Erypharm Procédé de production de cellules de culture à haute densité
CN114317392A (zh) * 2021-12-27 2022-04-12 无锡药明生物技术股份有限公司 优化细胞培养的方法
WO2023167584A1 (en) * 2022-03-01 2023-09-07 Biosanapharma B.V. Continuous manufacturing of a biological substance with process traceability
US20250250524A1 (en) * 2022-04-14 2025-08-07 Terasaki Institute For Biomedical Innovation Systems and methods for recycling growth factors and other components
WO2023205075A1 (en) * 2022-04-22 2023-10-26 Coopersurgical, Inc. Methods of culturing umbilical cord mesenchymal stem cells
IL319172A (en) * 2022-09-16 2025-04-01 Amgen Inc Method for collecting products in perfusate cultures
WO2024173685A1 (en) * 2023-02-15 2024-08-22 The Board Of Trustees Of The Leland Stanford Junior University Metabolic selection for glycogen-storing cells in vitro
WO2024248118A1 (ja) 2023-05-31 2024-12-05 富士フイルム株式会社 細胞培養方法および生産物の製造方法
CN121358529A (zh) 2023-06-20 2026-01-16 美国安进公司 用于色谱和色谱介质再利用的方法
WO2025184296A1 (en) * 2024-02-29 2025-09-04 Nature's Toolbox, Inc. In vitro rna production and purification system and methods of use thereof

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US5223428A (en) 1982-12-14 1993-06-29 Baxter International Inc. Method for in vitro culture of mammalian cells
AU588819B2 (en) 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
JP2507552B2 (ja) * 1988-08-29 1996-06-12 株式会社ニッショー 細胞培養産生物の取出しおよび培地の交換方法
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
US4937196A (en) 1989-08-18 1990-06-26 Brunswick Corporation Membrane bioreactor system
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
DE10399023I2 (de) 1989-09-12 2006-11-23 Ahp Mfg B V TFN-bindende Proteine
US6204363B1 (en) 1989-10-16 2001-03-20 Amgen Inc. Stem cell factor
US5149792A (en) 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs
US5272064A (en) 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
US5378612A (en) 1990-05-11 1995-01-03 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Culture medium for production of recombinant protein
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
WO1994010308A1 (en) 1992-10-23 1994-05-11 Immunex Corporation Methods of preparing soluble, oligomeric proteins
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US5981713A (en) 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
US5721121A (en) 1995-06-06 1998-02-24 Genentech, Inc. Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
ES2253753T3 (es) 1995-06-29 2006-06-01 Immunex Corporation Citocina que induce apoptosis.
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
US6068775A (en) * 1998-04-13 2000-05-30 Circe Biomedical, Inc. Removal of agent from cell suspension
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
WO2001036637A1 (en) 1999-11-17 2001-05-25 Immunex Corporation Receptor activator of nf-kappa b
US6544424B1 (en) 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
CN101255192A (zh) 2000-05-26 2008-09-03 布里斯托尔-迈尔斯斯奎布公司 可溶性ctla4突变体分子及其应用
AU9165201A (en) 2000-10-02 2002-04-15 Novo Nordisk As Factor vii glycoforms
US20040185535A1 (en) 2003-03-21 2004-09-23 Giles Wilson Industrial-scale serum-free production of recombinant FVII in mammalian cells
US7198940B2 (en) 2000-10-25 2007-04-03 Shot Hardware Optimization Technology, Inc. Bioreactor apparatus and cell culturing system
MY143582A (en) * 2001-06-26 2011-05-31 Amgent Fremont Inc Antibodies to opgl
JP2005532057A (ja) 2002-07-09 2005-10-27 バクスター・インターナショナル・インコーポレイテッド 細胞を培養するための動物性タンパク質非含有培地
ME00204B (me) * 2002-09-06 2011-02-10 Medarex Llc Terapijsko, humano, monoklonsko anti-il-1r1antitijelo
JP4541157B2 (ja) * 2002-12-23 2010-09-08 ブリストル−マイヤーズ スクイブ カンパニー タンパク質を製造するための哺乳類細胞培養法
DE10312765A1 (de) 2003-03-21 2004-09-30 Bayer Technology Services Gmbh Vorrichtung und Verfahren zur Sterilisation flüssiger Medien mittels UV-Bestrahlung und Kurzzeiterhitzung
US20050100965A1 (en) * 2003-11-12 2005-05-12 Tariq Ghayur IL-18 binding proteins
ES2605406T3 (es) * 2004-01-21 2017-03-14 Toray Industries, Inc. Fraccionador
CN104388324A (zh) * 2004-03-05 2015-03-04 帝斯曼知识产权资产管理有限公司 用于通过连续灌注和交互切向流来培养细胞的方法
US7422875B2 (en) 2004-07-20 2008-09-09 Board Of Regents Of The University Of Nebraska Compositions and methods for increasing protein production
US8053238B2 (en) 2005-10-31 2011-11-08 Unhwa Corporation Isolated population of plant single cells and method of preparing the same
DK2634242T3 (en) * 2006-07-14 2017-05-22 Patheon Holdings I B V IMPROVED PROCEDURE FOR CULTURING CELLS
WO2008024769A2 (en) * 2006-08-21 2008-02-28 Raven Biotechnologies, Inc. Intensified perfusion production method
BRPI0716762A2 (pt) 2006-09-13 2013-09-24 Abbott Lab melhorias da cultura celular
WO2008154014A2 (en) 2007-06-11 2008-12-18 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
EP2014760A1 (en) * 2007-06-13 2009-01-14 CMC Biopharmaceuticals A/S A method for producing a biopolymer (e.g. polypeptide) in a continuous fermentation process
DE602008006410D1 (de) 2007-06-15 2011-06-01 Amgen Inc Verfahren zur behandlung von zellkulturmedien für die verwendung in einem bioreaktor
ES2657055T3 (es) * 2007-08-09 2018-03-01 Wyeth Llc Uso de perfusión para mejorar la producción de un cultivo de células alimentado por lotes en biorreactores
AU2008345231B2 (en) 2007-12-27 2014-09-11 Takeda Pharmaceutical Company Limited Cell culture processes
DE102008051574A1 (de) 2008-10-14 2010-04-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung von Interferon-beta und deren Varianten
US20100120093A1 (en) 2008-11-12 2010-05-13 Baxter International Inc. Method of Producing Serum-Free Insulin-Free Factor VII
US8313926B2 (en) 2009-07-31 2012-11-20 Baxter International Inc. Methods for expressing ADAMTS proteins in cell culture medium supplemented with zinc
EP4406615A3 (en) * 2009-10-26 2024-12-11 F. Hoffmann-La Roche AG Method for the production of a glycosylated immunoglobulin
WO2011077035A1 (fr) 2009-12-23 2011-06-30 Sanofi Pasteur Procede de culture de cellules adherentes
CN107349671A (zh) * 2010-08-25 2017-11-17 瑞繁技术有限责任公司 流体过滤系统
DK2673072T3 (en) * 2011-02-10 2015-02-16 Crucell Holland Bv CELL SEPARATION SYSTEM WITH MEMBRANE WITH PNEUMATIC ALTERNATIVE PRESSURE
JP2014506482A (ja) 2011-02-23 2014-03-17 アムジエン・インコーポレーテツド Ｕｖｃ露光のための細胞培養培地およびそれに関連した方法
WO2012145682A1 (en) 2011-04-21 2012-10-26 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
US9115381B2 (en) 2011-05-13 2015-08-25 Octapharma Ag Method of increasing the productivity of eucaryotic cells in the production of recombinant FVIII
CA2838695C (en) * 2011-07-01 2017-02-14 Amgen Inc. Mammalian cell culture
WO2013040444A1 (en) 2011-09-16 2013-03-21 Amgen Inc. Pre-programmed non-feedback controlled continuous feeding of cell cultures
SG11201401739YA (en) 2011-10-26 2014-05-29 Amgen Inc Methods of reducing or eliminating protein modification and degradation arising from exposure to uv light
WO2013138159A1 (en) 2012-03-15 2013-09-19 Amgen Inc. Methods of determining exposure to uv light
US10481164B2 (en) 2012-03-26 2019-11-19 Amgen Inc. Method for using light scattering in real time to directly monitor and control impurity removal in purification processes
WO2014022102A1 (en) 2012-08-01 2014-02-06 Amgen Inc. Methods of using anti-apoptotic compounds to modulate one or more properties of a cell culture
TWI637057B (zh) 2012-11-09 2018-10-01 拜爾沙納有限公司 具交替生物反應器用途之不連續進料批次製程
ES2625510T3 (es) * 2012-11-26 2017-07-19 Gambro Lundia Ab Sistema de soporte hepático
DK2976418T3 (da) * 2013-03-19 2021-01-11 Cmc Biologics As Fremgangsmåde til fremstilling af et produkt (f.eks. polypeptid) i en kontinuerlig cellekulturfermenteringsproces

Also Published As

Publication number Publication date
US20220136025A1 (en) 2022-05-05
JP2022126811A (ja) 2022-08-30
US11427848B2 (en) 2022-08-30
JP2017519497A (ja) 2017-07-20
CA2951046C (en) 2023-06-13
JP7377316B2 (ja) 2023-11-09
ES2980493T3 (es) 2024-10-01
WO2015188009A9 (en) 2017-01-26
MX2016015944A (es) 2017-08-15
EA202192126A3 (ru) 2022-03-31
MX2021008142A (es) 2021-08-11
EP3152317A1 (en) 2017-04-12
AU2022224699A1 (en) 2022-09-22
CL2016003096A1 (es) 2017-11-03
KR102391259B1 (ko) 2022-04-26
JP7097404B2 (ja) 2022-07-07
US20170114381A1 (en) 2017-04-27
HUE042277T2 (hu) 2019-06-28
EA201692498A1 (ru) 2017-05-31
PT3926051T (pt) 2024-06-20
KR20220054903A (ko) 2022-05-03
CA3195249A1 (en) 2015-12-10
IL294430B1 (en) 2025-04-01
HUE066803T2 (hu) 2024-09-28
ES2909630T3 (es) 2022-05-09
JP2020124207A (ja) 2020-08-20
SI3926051T1 (sl) 2024-06-28
BR112016028285B1 (pt) 2023-02-23
SG11201610143VA (en) 2017-01-27
EA202192126A2 (ru) 2021-11-30
AU2020294155A1 (en) 2021-01-28
LT3152317T (lt) 2019-03-12
TR201900776T4 (tr) 2019-02-21
DK3152317T3 (en) 2019-04-08
US20220356502A1 (en) 2022-11-10
AU2015269365A1 (en) 2016-12-15
AU2019203538B2 (en) 2020-10-08
FI3926051T3 (fi) 2024-06-18
PL3152317T3 (pl) 2019-08-30
SG10202113019XA (en) 2021-12-30
EP3152317B1 (en) 2019-01-02
SI3152317T1 (sl) 2019-03-29
AU2024267090A1 (en) 2024-12-19
MX384212B (es) 2025-03-14
CA2951046A1 (en) 2015-12-10
CN106687575A (zh) 2017-05-17
CY1121217T1 (el) 2020-05-29
IL294430B2 (en) 2025-08-01
EP4372078A2 (en) 2024-05-22
CL2019001641A1 (es) 2019-10-25
EP3926051A1 (en) 2021-12-22
DK3926051T3 (da) 2024-06-10
BR122018011329A2 (pt) 2019-09-10
IL249150A0 (en) 2017-01-31
EP3521440A1 (en) 2019-08-07
US12195779B2 (en) 2025-01-14
LT3926051T (lt) 2024-06-10
ES2709994T3 (es) 2019-04-22
AU2019203538A1 (en) 2019-06-06
PT3152317T (pt) 2019-04-18
US11384378B2 (en) 2022-07-12
AU2020294155B2 (en) 2022-07-28
EP3926051B1 (en) 2024-05-08
EP3521440B1 (en) 2022-02-09
IL249150B (en) 2022-09-01
AU2022224699B2 (en) 2024-08-29
KR102598799B1 (ko) 2023-11-07
WO2015188009A1 (en) 2015-12-10
JP6695814B2 (ja) 2020-05-20
ZA201608303B (en) 2023-06-28
EA039148B1 (ru) 2021-12-10
IL319240A (en) 2025-04-01
IL294430A (en) 2022-09-01
MX2021008143A (es) 2021-08-11
CN106687575B (zh) 2021-04-30
KR20170015464A (ko) 2017-02-08
BR112016028285A2 (pt) 2018-06-26
EP4372078A3 (en) 2024-09-04

Similar Documents

Publication Publication Date Title
PL3926051T3 (pl) Sposoby zbierania hodowli komórek ssaczych
NO2025012I1 (no) Autologous anti-CD19-transduced CD3+ cells (brexucabtagene autoleucel)
IL292504B1 (en) -methods of preparing t cells for t cell therapy
IL256525A (en) Taurine supplemented cell culture medium and methods of use
IL286327A (en) Isolated discogenic cells, methods of using, and methods of preparing same from mammalian tissue
BR112017009540A2 (pt) biorreator usando macroalgas
EP2971014A4 (en) CELL CULTURE METHODS
EP2971040A4 (en) CELL CULTURE METHODS
DK3224351T3 (da) Dyrkningsmedium til ekspandering af brystepitelstamceller
EP3461890C0 (en) TOTAL FERMENTATION OF OLIGOSACCHARIDES
HUE066758T2 (hu) Eljárás allogén transplantációval kompatibilis T-sejtek elõállítására
DK3365107T3 (da) Cellekultur
EP3066193C0 (en) CELL CULTURE PROCESS
IL253071A0 (en) Methods for growing mammalian cells
EP3448986A4 (en) CELL CULTURE
HUE063273T2 (hu) Heteromultimer fehérjék elõállítása emlõssejtek felhasználásával
GB201608060D0 (en) Method of culturing T cells
IL270880A (en) Cell culture methods
IL247890A0 (en) Methods related to stem cells
DK2978839T3 (da) Fremgangsmåde til celledyrkning
SG11201609269TA (en) Method of culturing cells
FR3016372B1 (fr) Procede de preparation de cellules pluripotentes induites
GB201511482D0 (en) Culture of RPE cells
TH1501006595A (th) วิธีการเพาะเลี้ยงยีสต์
TH1501006905A (th) วิธีสำหรับการผลิตส่วนเพาะเลี้ยงเซลล์รูปแผ่น